Purple Biotech Ltd. (PPBT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Purple Biotech Ltd.

    NASDAQ: PPBT · Real-Time Price · USD
    0.62
    0.03 (4.41%)
    At close: Oct 06, 2025, 10:15 AM

    Purple Biotech Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.4M 14.49M 15.03M 10.89M
    Short-Term Investments
    		 1.12M 923K 17.08M 36.31M
    Long-Term Investments
    		 n/a n/a n/a 187K
    Other Long-Term Assets
    		 n/a n/a n/a 160K
    Receivables
    		 275K n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 109K 171K 146K 268K
    Total Current Assets
    		 8.91M 15.79M 33.26M 48.47M
    Property-Plant & Equipment
    		 288K 470K 682K 896K
    Goodwill & Intangibles
    		 27.84M 28.04M 20.68M 20.48M
    Total Long-Term Assets
    		 28.13M 28.51M 21.37M 21.73M
    Total Assets
    		 37.04M 44.3M 54.62M 70.2M
    Account Payables
    		 1.46M 3.53M 2.13M 1.47M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 183K n/a n/a n/a
    Other Current Liabilities
    		 966K 673K 698K 611K
    Total Current Liabilities
    		 3.99M 7.18M 7.06M 4.25M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 140K 2.66M 145K 292K
    Total Long-Term Liabilities
    		 140K 2.82M 466K 842K
    Total Liabilities
    		 4.13M 10.01M 7.52M 5.09M
    Total Debt
    		 183K 351K 515K 749K
    Book Value
    		 32.91M 34.3M 47.1M 65.11M
    Book Value Per Share
    		 12.73 27.86 50.97 73.15
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -144.69M -137.45M -117.58M -95.91M
    Comprehensive Income
    		 -98K -79K 10.06M 8.76M
    Shareholders Equity
    		 32.86M 34.21M 46.91M 64.83M
    Total Investments
    		 1.12M 923K 17.08M 36.5M

    Add to Watchlist